These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents. Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038 [TBL] [Abstract][Full Text] [Related]
3. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes. Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162 [TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy. Ma X; Lu J; Yang P; Zhang Z; Huang B; Li R; Ye R Dalton Trans; 2022 Sep; 51(36):13902-13909. PubMed ID: 36040403 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells. Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells. Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes. Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379 [TBL] [Abstract][Full Text] [Related]
8. Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance. Wei L; He X; Zhao D; Kandawa-Shultz M; Shao G; Wang Y Eur J Med Chem; 2024 Jan; 264():115985. PubMed ID: 38016298 [TBL] [Abstract][Full Text] [Related]
9. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity. Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands. Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859 [TBL] [Abstract][Full Text] [Related]
11. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion. Xie L; Wang L; Guan R; Ji L; Chao H J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250 [TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest. Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660 [TBL] [Abstract][Full Text] [Related]
13. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts. Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211 [TBL] [Abstract][Full Text] [Related]
15. New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity. Łomzik M; Mazuryk O; Rutkowska-Zbik D; Stochel G; Gros PC; Brindell M J Inorg Biochem; 2017 Oct; 175():80-91. PubMed ID: 28738277 [TBL] [Abstract][Full Text] [Related]
16. Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling. Chen J; Deng Y; Wang J; Chen S; Peng F; He X; Liu M; Luo H; Zhang J; Chen L J Biol Inorg Chem; 2021 Oct; 26(7):793-808. PubMed ID: 34459988 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells. Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780 [TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601 [TBL] [Abstract][Full Text] [Related]
19. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424 [TBL] [Abstract][Full Text] [Related]
20. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]